additional content
Exhibit 6: Government affairs (GA)
Previously, various silos were
responsible for answering these
questions and others. That,
inevitably, led to duplication of effort
and inconsistent messaging in the
marketplace. But now the stronger
and more coordinated capabilities
of the critical teams are essentially
serving as an early warning tool, a
way to sound the alarm within the
organization that an issue about
a planned or existing drug would
affect the company’s projected
performance and that tactics and
strategies would need to be altered
to address the potential problem.
The successful difference at this
pharmaceutical company can best
be described as a shift in emphasis
and in internal planning cohesion.
In the past, the commercial team
would go to market without enough
information to navigate conditions as
they changed; now, the commercial
team is benefiting from the collated
foresight that external-facing critical
teams are amassing, using this new
knowledge to drive a more logical
and lucrative marketplace strategy
for their leading brands.
supported by EUROBAK
121